⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Lineage Cell Therapeutics, Inc.

$1.03
+0.00 (+0.00%)

Market Capitalization:

$260.49M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Lineage Cell Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

-0.01(-0.96%)
Open$1.04
Close$1.03
Low$1.03
Low Change-0.01 (-0.96%)
High$1.04
High Change+0.00 (+0.00%)
Range$0.01
Volume62.412K
Dollar Volume$64.28K

Regular Trading Hours Yesterday

+0.00(+0.00%)
Open$1.03
Close$1.03
Low$1.01
Low Change-0.02 (-1.94%)
High$1.05
High Change+0.02 (+1.46%)
Range$0.04
Volume994.343K
Dollar Volume$1.02M

Premarket Yesterday

-0.01(-0.98%)
Open$1.02
Close$1.01
Low$1.00
Low Change-0.02 (-1.96%)
High$1.02
High Change+0.00 (+0.00%)
Range$0.02
Volume2.538K
Dollar Volume$2.56K

Lineage Cell Therapeutics News

There is no current news for this stock at the moment.

Lineage Cell Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Lineage Cell Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.01
10 Day Moving Average (SMA10)$0.99
20 Day Moving Average (SMA20)$0.97
50 Day Moving Average (SMA50)$1.02
100 Day Moving Average (SMA100)$1.10
200 Day Moving Average (SMA200)$1.33

Lineage Cell Therapeutics Statistics

Average Volume (30 Days)1.41M
P/E Ratio (Current)-7.62
EPS (Current)-$0.13
Dividend Yield0.00%
Free Cash Flow-$24.39M
Cash Ratio4.66
Current Ratio6.61
Quick Ratio6.61
Debt to Equity0.00
Enterprise Value$213.07M
EV to EBITDA-8.16
EV to Sales16.29
Price to Book4.11
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales19.14
Return on Assets-0.30%
Return on Equity-0.53%

Lineage Cell Therapeutics Stock Splits

There have been no stock splits for Lineage Cell Therapeutics (LCTX).

Lineage Cell Therapeutics Dividends

There have been no dividends for Lineage Cell Therapeutics (LCTX).